The 2023-2028 Outlook for Anti-Fatigue Cosmetics in China
US$ 595.00
This study covers the latent demand outlook for anti-fatigue cosmetics across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), mu...
August 2022
185 pages
The 2023-2028 Outlook for Anti-Fog Lidding Films in China
US$ 595.00
This study covers the latent demand outlook for anti-fog lidding films across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), mu...
August 2022
185 pages
The 2023-2028 Outlook for Anti-Icing Coatings in China
US$ 595.00
This study covers the latent demand outlook for anti-icing coatings across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), munic...
August 2022
185 pages
The 2023-2028 Outlook for Anti-Malarial Drugs in China
US$ 595.00
This study covers the latent demand outlook for anti-malarial drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), munic...
August 2022
185 pages
The 2023-2028 Outlook for Anti-Parkinson's Drugs in China
US$ 595.00
This study covers the latent demand outlook for anti-Parkinson's drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), mu...
August 2022
185 pages
The 2023-2028 Outlook for Anti-Reflective Coatings in China
US$ 595.00
This study covers the latent demand outlook for anti-reflective coatings across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet),...
August 2022
185 pages
The 2023-2028 Outlook for Anti-Snoring Treatments in China
US$ 595.00
This study covers the latent demand outlook for anti-snoring treatments across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), m...
August 2022
185 pages
The 2023-2028 Outlook for Anti Wrinkles Products in China
US$ 595.00
This study covers the latent demand outlook for anti wrinkles products across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), mu...
August 2022
185 pages
The 2023-2028 Outlook for Antibacterials in China
US$ 595.00
This study covers the latent demand outlook for antibacterials across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipali...
August 2022
185 pages
The 2023-2028 Outlook for Anticoagulant Drugs in China
US$ 595.00
This study covers the latent demand outlook for anticoagulant drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), munic...
August 2022
185 pages
The 2023-2028 Outlook for Anticoagulants in China
US$ 595.00
This study covers the latent demand outlook for anticoagulants across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipali...
August 2022
185 pages
The 2023-2028 Outlook for Antidepressant Drugs in China
US$ 595.00
This study covers the latent demand outlook for antidepressant drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), muni...
August 2022
185 pages
The 2023-2028 Outlook for Antidiarrheal Drugs in China
US$ 595.00
This study covers the latent demand outlook for antidiarrheal drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), munic...
August 2022
185 pages
The 2023-2028 Outlook for Antifibrinolytic Drugs in China
US$ 595.00
This study covers the latent demand outlook for antifibrinolytic drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), mu...
August 2022
185 pages
The 2023-2028 Outlook for Antifungal Azole Drugs in China
US$ 595.00
This study covers the latent demand outlook for antifungal azole drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), mu...
August 2022
185 pages
The 2023-2028 Outlook for Antifungal Drugs in China
US$ 595.00
This study covers the latent demand outlook for antifungal drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipa...
August 2022
185 pages
The 2023-2028 Outlook for Antihypertensive Drugs in China
US$ 595.00
This study covers the latent demand outlook for antihypertensive drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), mu...
August 2022
185 pages
The 2023-2028 Outlook for Antihypertensives in China
US$ 595.00
This study covers the latent demand outlook for antihypertensives across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municip...
August 2022
185 pages
The 2023-2028 Outlook for Antipsychotic Drugs in China
US$ 595.00
This study covers the latent demand outlook for antipsychotic drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), munic...
August 2022
185 pages
The 2023-2028 Outlook for Antipsychotics in China
US$ 595.00
This study covers the latent demand outlook for antipsychotics across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipali...
August 2022
185 pages
The 2023-2028 Outlook for Antiulcerant Drugs in China
US$ 595.00
This study covers the latent demand outlook for antiulcerant drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), munici...
August 2022
185 pages
